Selective inhibition of soluble tumor necrosis factor signaling reduces abdominal aortic aneurysm progression

BACKGROUND: Tumor necrosis factor (TNF) is pathologically elevated in human abdominal aortic aneurysms (AAA). Non-selective TNF inhibition-based therapeutics are approved for human use but have been linked to several side effects. Compounds that target the proinflammatory soluble form of TNF (solTNF...

Descripción completa

Detalles Bibliográficos
Autores principales: Griepke, Silke, Grupe, Emilie, Lindholt, Jes Sanddal, Fuglsang, Elizabeth Hvitfeldt, Steffensen, Lasse Bach, Beck, Hans Christian, Larsen, Mia Dupont, Bang-Møller, Sissel Karoline, Overgaard, Martin, Rasmussen, Lars Melholt, Lambertsen, Kate Lykke, Stubbe, Jane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523116/
https://www.ncbi.nlm.nih.gov/pubmed/36186984
http://dx.doi.org/10.3389/fcvm.2022.942342

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523116/
https://www.ncbi.nlm.nih.gov/pubmed/36186984
http://dx.doi.org/10.3389/fcvm.2022.942342

Ejemplares similares